## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a
✦ LIBER ✦
A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients
✍ Scribed by M. Riedel; F.X. Eich; H.J. Möller
- Book ID
- 118439896
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- French
- Weight
- 168 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0924-9338
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Long-term safety and efficacy of long-ac
✍
Werner Kissling; Per Glue; Rossella Medori; Steve Simpson
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 144 KB
👁 1 views
Efficacy and safety of fluvastatin in el
✍
G. Baggio; O. De Candia; P.L. Forte; F. Mello; A. Andriolli; S. Donazzan; G. Val
📂
Article
📅
1994
🏛
Elsevier Science
🌐
English
⚖ 421 KB
39-3 - Efficacy of risperidone in psycho
✍
W. Wittgens; M. Girard; E. Klieser
📂
Article
📅
1997
🏛
Elsevier Science
🌐
English
⚖ 255 KB
P.3.a.015 Study of the efficacy and safe
✍
Y. Inoue; H. Suzuki; M. Ootomo; S. Takeda; Y. Kawaguchi; K. Gen
📂
Article
📅
2010
🏛
Elsevier Science
🌐
English
⚖ 42 KB
P.3.133 Risperidone long acting injectab
📂
Article
📅
2005
🏛
Elsevier Science
🌐
English
⚖ 121 KB
Efficacy and safety of long-acting rispe
✍
Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 93 KB
👁 2 views
## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi